Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.
about
Rho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth.Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new.Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy.Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, ArgentinaRepurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPrimary Angiosarcoma of the Spleen: Rare Diagnosis with Atypical Clinical CourseNext generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancerDrug repurposing in oncology--patient and health systems opportunities.Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside StudyMetastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way.Beta-adrenergic receptors are expressed across diverse cancers.Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol.Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma.Cutaneous angiosarcoma: update on biology and latest treatment.Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0/G1/S phase arrest in malignant melanoma.Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.Propranolol for the treatment of vascular sarcomasRegression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment
P2860
Q33909559-B2F66320-FC74-4DC3-B113-76D0322D55BAQ36389964-D5BFD4EA-0AF2-453F-891D-6B465F9E0158Q37158433-C5C9B8FB-A920-4E27-99B6-1B06FE63429FQ37239002-A1BAB7EC-3AF2-4749-B47E-EF88BCC28D66Q37404693-C8B86443-7B14-4DBE-B079-6B86DF3B6206Q37404756-332B0DDA-38D3-4C55-B24F-67298E6C6293Q37458763-5475911B-A193-4F77-839C-9949E8DC225AQ37701617-992D6E0A-CC08-4FB7-A652-A06563C16DA8Q38611707-4A350F08-2A27-46FD-9D50-7E03B99BC20FQ38769283-B7D9D347-5706-40D7-9E8F-66CDF32A9B9EQ41601904-D9A33E33-4867-460C-A0E0-CB7D43FBA33FQ41667468-DF039486-287D-4E47-991A-0683ED19D642Q41783972-1BFCACCC-0BDB-4B53-A3CE-BB2B93CA352DQ47101799-AE3B8387-68C0-41AD-B147-16CD04C7A4C1Q47807442-06B55991-B436-499D-9A20-D8446A80251DQ49386480-19360C64-890D-4FAB-A2E5-CBB46F4A60A3Q55192373-23399DBC-BA68-4B2A-81F3-C9CFF635AD7CQ58761654-D535D4EB-C05B-4CF5-930A-F0E66B9E3E48Q59136527-A8AF9B49-7C1B-4025-9267-69B014B85FCA
P2860
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeted therapy with proprano ...... psing metastatic angiosarcoma.
@ast
Targeted therapy with proprano ...... psing metastatic angiosarcoma.
@en
type
label
Targeted therapy with proprano ...... psing metastatic angiosarcoma.
@ast
Targeted therapy with proprano ...... psing metastatic angiosarcoma.
@en
prefLabel
Targeted therapy with proprano ...... psing metastatic angiosarcoma.
@ast
Targeted therapy with proprano ...... psing metastatic angiosarcoma.
@en
P2860
P356
P1476
Targeted therapy with proprano ...... apsing metastatic angiosarcoma
@en
P2093
Nicolas Andre
Shripad Banavali
P2860
P356
10.3332/ECANCER.2015.499
P577
2015-01-08T00:00:00Z